IT1238210B - Cefamandol naftate esters, preparation procedure and relative pharmaceutical compositions.
- Google Patents
Cefamandol naftate esters, preparation procedure and relative pharmaceutical compositions.
Info
Publication number
IT1238210B
IT1238210BIT02205589AIT2205589AIT1238210BIT 1238210 BIT1238210 BIT 1238210BIT 02205589 AIT02205589 AIT 02205589AIT 2205589 AIT2205589 AIT 2205589AIT 1238210 BIT1238210 BIT 1238210B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magis FarmaceuticifiledCriticalMagis Farmaceutici
Priority to IT02205589ApriorityCriticalpatent/IT1238210B/en
Publication of IT8922055A0publicationCriticalpatent/IT8922055A0/en
Publication of IT8922055A1publicationCriticalpatent/IT8922055A1/en
Application grantedgrantedCritical
Publication of IT1238210BpublicationCriticalpatent/IT1238210B/en
This describes the esters of acid 7-(D-2-formyloxy-2-phenyl-acetamide)-3-(1-methyl-1-H-tetrazole-5-yl)-thiomethyl-3-cephem-4-carboxylic with alkoxy -2-propanol in optically active or racemic form, which, when utilized in bacterial disease therapy, are absorbed by mouth in notably superior quantities respect to the acid administered in the same way.
Protein c inhibitor (pci) as pharmaceutical and in vitro diagnostic aid, a process for the preparation of a pharmaceutical or diagnostic aid of this type, and an agent containing pci
Combination of sulpiride and diazepam as a pharmaceutical composition which is useful, in particular, in the treatment of stress-linked functional digestive manifestations, and its use for the preparation of the aforementioned composition